Boxer Capital’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Boxer Capital’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-450,000	Closed	-$167K	–	84
2023 Q2	$167K	Buy	+450,000	New	+$243K	0.01%	77
2023 Q1	–	Sell	-56,950	Closed	-$41K	–	78
2022 Q4	$41K	Hold	56,950	–	–	﹤0.01%	69
2022 Q3	$68K	Hold	56,950	–	–	﹤0.01%	71
2022 Q2	$68K	Hold	56,950	–	–	﹤0.01%	75
2022 Q1	$123K	Buy	+56,950	New	+$92.6K	0.01%	73
2018 Q2	–	Sell	-35,000	Closed	-$2.3M	–	32
2018 Q1	$2.3M	Buy	+35,000	New	+$2.64M	0.25%	28

Boxer Capital's BLCM Position: Q3 2023 in Review

Boxer Capital sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q3 2023, closing a stake of 450,000 shares — an estimated $167K sold.

Boxer Capital first reported a position in BLCM in Q1 2018 and held it in 6 quarters. The position peaked at $2.3M in Q1 2018. 0 funds tracked by Wall St. Rank hold BLCM as of Q3 2023.

Boxer Capital reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
Boxer Capital sold 450,000 Bellicum Pharmaceuticals, Inc. shares in Q3 2023, an estimated $167K.
Boxer Capital first reported a position in Bellicum Pharmaceuticals, Inc. in Q1 2018 and held it in 6 quarters.
Boxer Capital's Bellicum Pharmaceuticals, Inc. position peaked at $2.3M in Q1 2018.
0 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q3 2023.

Based on Boxer Capital's 13F filing for Q3 2023, filed 14 Nov 2023.